Experimental Leukemia and Mammary Cancer: Induction, Prevention, Cure, Huggins
The book Experimental Leukemia and Mammary Cancer: Induction, Prevention, Cure, Charles Brenton Huggins is published by ... Induction of Leukemia Leukemia in S-D Rat Leukemia in L-E Rat Recognition of Leukemia Transplantation of Blood from Leukemic ... Induction of Leukemia by Intravenous Injection of 7,12-DMBA in Mouse Induction of Leukemia by Feeding 7,12-DMBA in Mouse ... Types of Hydrocarbon-Induced Leukemia Extinction of Leukemia by Endocrine Methods Erythroleukemia, Anemia, and Erythropoietin 9 ...http://press.uchicago.edu/ucp/books/book/chicago/E/bo3622967.html
"Evidence of viral implication in experimental leukemia induced by n-ni" by N Imamura
Imamura, N, "Evidence of viral implication in experimental leukemia induced by n-nitrosobutylurea in mice." (1973). Subject ... Evidence of viral implication in experimental leukemia induced by n-nitrosobutylurea in mice. ...https://mouseion.jax.org/ssbb1973/1890/
Content of squalene and sterols in tissues of the hemopoietic system in normal rats and in experimental leukemia
... ... Content of squalene and sterols in tissues of the hemopoietic system in normal rats and in experimental leukemia, Voprosy ... bone marrow and liver tissue of rats with experimental leukosis. Scvalene was increased in kidney tissue. Simultaneous ... were studied in lymphoid tissues as well as in liver and kidney tissues of normal rats and the animals with Shvetz experimental ...http://pbmc.ibmc.msk.ru/index.php/en/article/PBMC-1983-29-3-64-en
Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute...
... in acute leukemia (AL) with biochemical markers - "N-terminal pro brain natriuretic peptide" (NT-proBNP), cardiac troponin T ( ... markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia. ... of cardiac biomarkers in detection of cardiotoxicity associated with conventional and high-dose chemotherapy for acute leukemia ...http://exp-oncology.com.ua/article/395/biochemical-markers-and-assessment-of-cardiotoxicity-during-preparative-regimen-and-hematopoietic-cell-transplantation-in-acute-leukemia
Alterations in composition of sterols and in properties of erythrocyte membranes in rats with Shvetz experimental leukemia and...
Alterations in composition of sterols and in properties of erythrocyte membranes in rats with Shvetz experimental leukemia and ... Alterations in composition of sterols and in properties of erythrocyte membranes in rats with Shvetz experimental leukemia and ... increased in erythrocyte membranes of rats with Shvetz experimental leukosis. At the same time, osmotic stability of ...http://pbmc.ibmc.msk.ru/index.php/en/article/PBMC-1983-29-3-67-en
"Chemotherapy of experimental meningeal leukemia. Abstr." by F M. Schabel, T P. Johnston et al.
Schabel, F M.; Johnston, T P.; Caleb, G S.; Montgomery, J A.; Laster, R.; and Skipper, H E., "Chemotherapy of experimental ... meningeal leukemia. Abstr." (1963). Subject Strain Bibliography 1963. 918. https://mouseion.jax.org/ssbb1963/918 ...https://mouseion.jax.org/ssbb1963/918/
IGHV3-21 gene expression in patients with B-cell chronic lymphocytic leukemia in Ukraine | Experimental oncology
... the frequency of IGHV3-21 gene usage and its clinical significance for patients with B-cell chronic lymphocytic leukemia ... IGHV3-21 gene expression in patients with B-cell chronic lymphocytic leukemia in Ukraine. Abramenko I., Bilous N.I., Kryachok I ... chronic lymphocytic leukemia, IGHV3-21, immunoglobulin variable heavy chain gene, prognostic factor. ... the frequency of IGHV3-21 gene usage and its clinical significance for patients with B-cell chronic lymphocytic leukemia (CLL) ...http://exp-oncology.com.ua/article/401/ighv3-21-gene-expression-in-patients-with-b-cell-chronic-lymphocytic-leukemia-in-ukraine
Study Information for: "Treatment with an experimental drug in patients with newly diagnosed Acute Lymphoblastic Leukemia." -...
Treatment with an experimental drug in patients with newly diagnosed Acute Lymphoblastic Leukemia. ... Treatment with an experimental drug in patients with newly diagnosed Acute Lymphoblastic Leukemia.. ... treatment with blinatumomab has on BCR/ABL negative Acute Lymphoblastic Leukemia. ...http://www.wakehealth.edu/BeInvolved/StudyInfo.aspx?study=IRB00027899&title=Treatment%20with%20an%20experimental%20drug%20in%20patients%20with%20newly%20diagnosed%20Acute%20Lymphoblastic%20Leukemia
"Experimental investigations in murine akm leukemia." by E Nastac, B Anagnoste et al.
Nastac, E; Anagnoste, B; and Balmus, G, "Experimental investigations in murine akm leukemia." (1963). Subject Strain ...https://mouseion.jax.org/ssbb1963/1232/
Role of N-acetyl-D-galactosamine residue on B151K12-derived T cell-replacing factor (B151-TRF) molecule in B cell-receptor...
Leukemia, Experimental / metabolism. Lymphocyte Activation*. Lymphokines / analysis, metabolism, physiology*. Mice. Mice, ...http://www.biomedsearch.com/nih/Role-N-acetyl-D-galactosamine/3897376.html
Recruitment of quiescent tumor by humoral stimulatory activity: requirements for successful chemotherapy.
Acute leukemia is a heterogeneous tumor with respect to cellular proliferation and is sensitive to positive and negative growth ... Leukemia / drug therapy*, pathology. Leukemia, Experimental / drug therapy. Rats. Grant Support. ID/Acronym/Agency: CA-066973/ ... Acute leukemia is a heterogeneous tumor with respect to cellular proliferation and is sensitive to positive and negative growth ... Our in vivo studies of timed sequential chemotherapy in human leukemia demonstrate than an increase in tumor labeling index (LI ...http://www.biomedsearch.com/nih/Recruitment-quiescent-tumor-by-humoral/7159763.html
Charlotte Friend, PhD, Papers, 1935-1987 | Icahn School of Medicine
Leukemia, Experimental. Mount Sinai School of Medicine. Graduate School of Biological Sciences: Box 39-40. National Academy of ... Human Leukemia--Articles; Clippings; Organizational meeting NCI Acute Leukemia Task Force, Leukemia Etiology Subgroup; " ... Friend C. "Experimental studies on a virus-induced leukemia of mice," 1960. ... Friend C. "Leukemia of Adult Mice Caused by a Transmissible Agent," in Annals of the NY Academy of Sciences, v.68, ART.2, Oct. ...http://icahn.mssm.edu/about/ait/archives/collection/charlotte-friend
Möglichkeiten und Grenzen internistischer Behandlung Krebskranker | SpringerLink
On the criteria and kinetics associated with "curability" of experimental leukemia. Cancer Chemother Rep 55: 1-111Google ... Skipper HE, Schabel FM, Wilcox WS (1964) Experimental evaluation of potential anticancer agents. XII. ...https://link.springer.com/chapter/10.1007/978-3-642-75831-7_8
Neoadjuvant Versus Adjuvant Chemotherapy in Invasive Bladder Cancer | Springer for Research & Development
On the criteria and kinetics associated with curability of experimental leukemia. Cancer Chemother Rep 35:1-9PubMedGoogle ... Skipper HE, Schabel FM, Wilcox WS (1964) Experimental evaluation of potential anticancer agents. XII. ...https://rd.springer.com/chapter/10.1007/978-3-642-84583-3_18
2 Experimental Drugs Show Promise for Rare Pancrea... ( By Maureen Salamon HealthDay Rep...)
10 issue of the New England ...,2,Experimental,Drugs,Show,Promise,for,Rare,Pancreatic,Cancer,medicine,medical news today,latest ... Experimental Test May Spot Prostate Cancer Earlier, More Accurately. 11. Experimental Leukemia Drug Proves a Slam Dunk. ... Experimental vaccine sets sights on lung cancer. 7. Experimental Drug Raises Good Cholesterol Levels in Early Trial. 8. UT ... Experimental approach may improve healing of diabetic wounds and bed sores. 2. Study raises safety concerns about experimental ...http://www.bio-medicine.org/medicine-news-1/2-Experimental-Drugs-Show-Promise-for-Rare-Pancreatic-Cancer-79123-1/
Sunesis Spin Doctor Tiptoes Around Failed Leukemia Drug Trial - TheStreet
... experimental leukemia drug vosaroxin underwent a miraculous transformation during a Sunday morning press briefing at the ... Sunesis Spin Doctor Tiptoes Around Failed Leukemia Drug Trial. Sunesis' experimental leukemia drug vosaroxin underwent a ... SAN FRANCISCO (TheStreet) -- Sunesis Pharmaceuticals' (SNSS) experimental leukemia drug vosaroxin underwent a miraculous ... Vosaroxin should be considered a new standard of care for elderly patients with relapsed acute myeloid leukemia, based on a ...https://www.thestreet.com/story/12976752/1/sunesis-spin-doctor-tiptoes-around-failed-leukemia-drug-trial.html
SFB 1074 - Ulm University
SFB 1074 - Experimental Models and Clinical Translation in Leukemia First Funding Period: 01.07.2012 - 30.06.2016. Second ... functional characterization of leukemia samples from patients with acute and chronic leukemia and/or human-derived experimental ... Projects in Group A use a broad spectrum of physiologically relevant in vitro and in vivo experimental systems to investigate ... It is hoped that this approach will substantially contribute to improved understanding of leukemia biology, and, importantly, ...https://www.uni-ulm.de/?id=41680
PDB 1pvl structure summary ‹ Protein Data Bank in Europe (PDBe) ‹ EMBL-EBI
Is LukS-PV a novel experimental therapy for leukemia? Shan et al. (2017) ...http://www.ebi.ac.uk/pdbe/entry/pdb/1PVL
Lloyd J. Old - Wikipedia
1964 Dec 5;2(7371): 1207-9. Old LJ, Boyse EA, Stockert E. Antigenic properties of experimental leukemias. I. Serological ... First coined TL (for "thymus-leukemia" antigen in mice) then later as the Ly series (originally named Ly-A and Ly-B and later ... Boyse EA, Old LJ, Luell S. Genetic determination of the TL (thymus-leukemia) antigen in the mouse. Nature 1964; 201:779. Boyse ... Introduced Bacille Calmette-Guérin (BCG), the tuberculosis vaccine, into experimental cancer research as a way to stimulate non ...https://en.wikipedia.org/wiki/Lloyd_J._Old
Biotech Stock Roundup: HCV Back in Focus - Idenix, Achillion Soar
... as partner Celgene opted to acquire development and commercialization rights to experimental leukemia drug, AG-221. ... The experimental drug is currently in phase III studies and if approved will target the highly lucrative oral multiple ... Receptos Gains on Promising Data: Receptos' shares are up a whopping 36.8% on positive mid-stage data on its experimental ... GW Pharma Shoots Up: GW Pharma saw its shares shooting up 16.3% on encouraging data on its experimental epilepsy treatment, ...https://finance.yahoo.com/news/biotech-stock-roundup-hcv-back-133346959.html
Effect of dietary zinc intake on mammary tumorigenesis induced by N-methyl-N-nitrosourea in rats - UBC Library Open Collections
In: Experimental leukemia and mammary cancer. Chicago: University of Chicago Press, 1979:73-79. Hunter DJ, Willett WC. Diet, ... These experimental diets were formulated based on the modified egg-white based AIN-93G diet. A l l the nutrients in the diets ... The tumor incidence in PZ31 rats was not significantly different from that in Z3 rats over the experimental period. These ... The number of palpable tumors over the experimental period followed a similar pattern as the tumor incidence (Figure 4). The ...https://open.library.ubc.ca/cIRcle/collections/ubctheses/831/items/1.0089205
Anti-PML Antibody, clone 36.1-104 | 05-718
Detect PML also known as Promyelocytic Leukemia Protein with Anti-PML Antibody, clone 36.1-104 (Mouse Monoclonal Antibody), ... Expression of AE9a leads to rapid development of leukemia in experimental mouse systems. We have recently shown that treatment ... Promyeloctic Leukemia Gene product (PML) is a nuclear protein with growth-suppressive properties originally identified in the ... Promyelocytic leukemia nuclear bodies (PML NBs) are involved in the regulation of apoptosis, antiviral responses, the DNA ...http://www.merckmillipore.com/INTL/en/product/Anti-PML-Antibody-clone-36.1-104,MM_NF-05-718
Table of Contents | Cancer Prevention Research
Chemopreventive Effects of Dietary Eicosapentaenoic Acid Supplementation in Experimental Myeloid Leukemia. Emily R. Finch, ...http://cancerpreventionresearch.aacrjournals.org/content/8/10
Disputation - Lotta Ohm | Event | KI Nyheter | Karolinska Institutet
... experimental and health economic studies, with special reference to imatinib treatmentOpponent Professor Hans Wadenvik ... Chronic myeloid leukemia - clinical, experimental and health economic studies, with special reference to imatinib treatment ...https://ki.se/nyheter/kalender/disputation-lotta-ohm
Vasostatin, a Calreticulin Fragment, Inhibits Angiogenesis and Suppresses Tumor Growth | JEM
1995) Regression of experimental human leukemias and solid tumors induced by Epstein-Barr virus-immortalized B cells. Leuk ... 1997) Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390:404-407, pmid:9389480. ... Journal of Experimental Medicine Dec 1998, 188 (12) 2349-2356; DOI: 10.1084/jem.188.12.2349 ... 1994) Regression of experimental Burkitt's lymphoma induced by Epstein-Barr virus-immortalized human B cells. Blood 83:776-784 ...http://jem.rupress.org/content/188/12/2349
Download our free solidary book to support research on VHL disease